Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection
Article
[키워드] acute respiratory syndrome
animal model
anti-SARS-CoV-2
baseline
Body weight loss
caused
China
controls
convalescent plasma
coronavirus
COVID-19
COVID-19 vaccines
deaths
Efficacy
evaluated
faster
hamster
hamsters
Hospitalization
Human
Immunoglobulin
intravenous
Lung inflammation
Lung pathology
Lungs
mice
monoclonal antibody
mouse model
ongoing trial
PBS
plasma
reduced
SARS-CoV-2
SARS-COV-2 infection
significantly
Spread
Support
therapeutic option
treated
Treatment
Viral load
virus
was reduced
worldwide pandemic
[DOI] 10.1038/s41598-022-21223-2 PMC 바로가기
[DOI] 10.1038/s41598-022-21223-2 PMC 바로가기